Erdosteine

Drugs
K L Dechant, S Noble

Abstract

Erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. Erdosteine contains 2 blocked sulfhydryl groups which are released following first-pass metabolism. The 3 active metabolites exhibit mucolytic and free radical scavenging activity. Erdosteine modulates mucus production and viscosity and increases mucociliary transport, thereby improving expectoration. It also exhibits inhibitory activity against the effects of free radicals produced by cigarette smoke. Clinical studies in patients with chronic obstructive lung disease have demonstrated the efficacy and tolerability of erdosteine. Erdosteine 300mg twice daily reduced cough (both frequency and severity) and sputum viscosity more quickly and more effectively than placebo and reduced the adhesivity of sputum more effectively than ambroxol 30mg twice daily. Co-administration of erdosteine and amoxicillin in patients with acute infective exacerbation of chronic bronchitis resulted in higher concentrations of the antibiotic in the sputum, leading to earlier and more pronounced amelioration of clinical symptoms compared with placebo. Erdosteine is associated with a low incidence o...Continue Reading

Citations

Feb 18, 2011·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Narin DerinMutay Aslan
Mar 3, 2005·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·M Tayyar KalciogluOrhan Ozturan
Nov 15, 2007·Antioxidants & Redox Signaling·Brian J Day
Jan 12, 2007·Pediatric Surgery International·Göksel SenerNursal Gedik
Apr 14, 2007·Digestive Diseases and Sciences·Göksel SenerBerrak C Yeğen
Oct 1, 2009·International Urology and Nephrology·Talat YurdakulVolkan Kocabas
Jan 11, 2008·Lung·Roberto W Dal Negro
Sep 22, 2012·European Journal of Clinical Pharmacology·Sepideh ElyasiSimin Dashti-Khavidaki
Jan 9, 2003·Journal of Applied Toxicology : JAT·Ersin FadillioğluIrfan Kuku
Jul 11, 2006·Pharmacology·Pier Carlo BragaLaura Marabini
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Maurizio Moretti
Jan 5, 2002·Expert Opinion on Investigational Drugs·Duncan F Rogers
Oct 20, 2010·Drug and Chemical Toxicology·Elife ErarslanTuncay Delibasi
Jun 10, 2009·The Journal of Surgical Research·Turan TuncAhmet Guven
Jun 19, 2007·The Journal of Surgical Research·Mehmet SirmaliNamik Delibaş
Feb 3, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Maurizio Moretti, Carlo Felice Marchioni
Jan 12, 2007·Journal of Applied Toxicology : JAT·Rezan DemiralayHavva Erdem
Mar 9, 2011·Environmental Toxicology·Ahmet YesilyurtAynur Albayrak
Jun 24, 2004·European Journal of Pharmacology·Sadik SogutZeki Yildirim
Dec 3, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R DokuyucuM Duru
Feb 10, 2011·Journal of Cardiothoracic Surgery·Sami KarapolatAyhan Saritas
Nov 24, 2016·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Sofia WaissbluthSam J Daniel
Jan 21, 2011·Human & Experimental Toxicology·Vefik AricaHasan Kaya
Jul 24, 2008·Toxicologic Pathology·Guven KuvandikSadik Sogüt
Nov 5, 2011·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Sofia WaissbluthSam J Daniel
Mar 7, 2020·Expert Review of Respiratory Medicine·Federica Lo BelloGaetano Caramori
Mar 22, 2005·Drugs in R&D·Ilknur BasyigitOlcay Bulut
Dec 6, 2005·Molecular and Cellular Biochemistry·Haşim BoyaciCengiz Erçin
Jun 9, 2005·Toxicology and Industrial Health·Alpaslan TerziErsin Fadillioglu
Oct 17, 2012·Toxicology and Industrial Health·Ayhan SaritasIsmail Hamdi Kara
Nov 3, 2011·Human & Experimental Toxicology·M TutancM Aydin
Sep 24, 2005·Molecular and Cellular Biochemistry·Ahmet KocSadik Sogut

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.